Journal of Gastroenterology and Hepatology

Papers
(The H4-Index of Journal of Gastroenterology and Hepatology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Covid‐19 and the digestive system485
Gastric cancer prevention strategies: A global perspective146
Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic123
Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial105
Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis90
Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrow‐band imaging83
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients74
Intestinal microbiota and its association with colon cancer and red/processed meat consumption70
Opening the black box of AI‐Medicine65
Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis62
Post‐infection functional gastrointestinal disorders following coronavirus disease‐19: A case–control study61
Relationship between dietary patterns and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis57
Regulation of lipid‐induced macrophage polarization through modulating peroxisome proliferator‐activated receptor‐gamma activity affects hepatic lipid metabolism via a Toll‐like receptor 4/NF‐κB signa54
Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea‐predominant irritable bowel syndrome: A prospective, randomized trial54
The impact of deep convolutional neural network‐based artificial intelligence on colonoscopy outcomes: A systematic review with meta‐analysis52
Impacts of the COVID‐19 pandemic on functional dyspepsia and irritable bowel syndrome: A population‐based survey51
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia47
Artificial intelligence in small bowel capsule endoscopy ‐ current status, challenges and future promise46
Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non‐alcoholic fatty liver disease44
Vonoprazan‐containingHelicobacter pyloritriple therapies contribution to global antimicrobial resistance44
The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease44
Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis43
Systematic review with meta‐analysis: The effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease43
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals42
Prevalence of the pathobiont adherent‐invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta‐analysis42
Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis40
Artificial liver support systems39
Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in‐hospital mortality39
Artificial intelligence in colonoscopy ‐ Now on the market. What's next?39
COVID‐19, nausea, and vomiting38
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study37
Artificial intelligence in precision medicine in hepatology36
Systematic review and meta‐analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease36
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease36
Fecal microbiota transplantation therapy in Crohn's disease: Systematic review35
Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy35
0.067938089370728